These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7697734)

  • 21. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 infection: functional competition between gp41 and interleukin-2.
    Sanhadji K; Tardy JC; Touraine JL
    C R Biol; 2010 Aug; 333(8):608-12. PubMed ID: 20688281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides.
    Cauda R; Tumbarello M; Ortona L; Kennedy RC; Shuler KR; Chanh TC; Kanda P
    Nat Immun Cell Growth Regul; 1990; 9(6):366-75. PubMed ID: 2087245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Transmembrane Domain of HIV-1 gp41 Inhibits T-Cell Activation by Targeting Multiple T-Cell Receptor Complex Components through Its GxxxG Motif.
    Rotem E; Reuven EM; Klug YA; Shai Y
    Biochemistry; 2016 Feb; 55(7):1049-57. PubMed ID: 26828096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.
    Quintana FJ; Gerber D; Kent SC; Cohen IR; Shai Y
    J Clin Invest; 2005 Aug; 115(8):2149-58. PubMed ID: 16007266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.
    Ruegg CL; Strand M
    Cell Immunol; 1991 Oct; 137(1):1-13. PubMed ID: 1832084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection.
    Cheingsong-Popov R; Panagiotidi C; Caun K; Klasse PJ; Pipkorn R; Blomberg J; Weber J
    AIDS; 1990 Mar; 4(3):251-3. PubMed ID: 2350445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection.
    Blackburn R; Clerici M; Mann D; Lucey DR; Goedert J; Golding B; Shearer GM; Golding H
    Adv Exp Med Biol; 1991; 303():63-9. PubMed ID: 1805576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation.
    Denner J; Persin C; Vogel T; Haustein D; Norley S; Kurth R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):442-50. PubMed ID: 8757420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation.
    Chen YH; Christiansen A; Dierich MP
    Immunol Lett; 1995 Nov; 48(1):39-44. PubMed ID: 8847089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 Motif.
    Klug YA; Schwarzer R; Rotem E; Charni M; Nudelman A; Gramatica A; Zarmi B; Rotter V; Shai Y
    Biochemistry; 2019 Feb; 58(6):818-832. PubMed ID: 30602116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods.
    Närvänen A; Korkolainen M; Kontio S; Suni J; Turtianen S; Partanen P; Soos J; Vaheri A; Huhtala ML
    AIDS; 1988 Apr; 2(2):119-23. PubMed ID: 3132938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecularly Imprinted Polymer Nanoparticles as Potential Synthetic Antibodies for Immunoprotection against HIV.
    Xu J; Merlier F; Avalle B; Vieillard V; Debré P; Haupt K; Tse Sum Bui B
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9824-9831. PubMed ID: 30758939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of HIV-specific lymphoproliferation in HIV-infected individuals by TraT: a novel T-cell immunopotentiating agent.
    Bell SJ; Geczy AF; Russell-Jones GJ; Croft S; Cooper DA; Penny R
    AIDS; 1993 Jun; 7(6):807-12. PubMed ID: 8363757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1.
    Denner J; Eschricht M; Lauck M; Semaan M; Schlaermann P; Ryu H; Akyüz L
    PLoS One; 2013; 8(1):e55199. PubMed ID: 23383108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.
    Faingold O; Ashkenazi A; Kaushansky N; Ben-Nun A; Shai Y
    J Biol Chem; 2013 Nov; 288(46):32852-60. PubMed ID: 24078631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation.
    Cianciolo GJ; Bogerd H; Snyderman R
    Immunol Lett; 1988 Sep; 19(1):7-13. PubMed ID: 2973436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.
    Chanh TC; Kennedy RC; Kanda P
    Cell Immunol; 1988 Jan; 111(1):77-86. PubMed ID: 3257417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.